Skinvisible (SKVI) Capital Expenditures (2018 - 2025)

Skinvisible (SKVI) has 7 years of Capital Expenditures data on file, last reported at -$1.0 in Q3 2025.

• For the quarter ending Q3 2025, Capital Expenditures changed N/A year-over-year to -$1.0; the trailing twelve-month figure through Dec 2025 stood at -$1.0 (changed 0.0% YoY), and the FY2025 full-year result was $4086.0, down 55.67% from the prior year.
• Capital Expenditures steadied at -$1.0 in Q3 2025, from -$1.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $20414.0 in Q2 2021 to a low of -$1.0 in Q3 2023.
• A 4-year average of $4388.7 and a median of $525.0 in 2022 frame the typical range for Capital Expenditures.
• Peak annual rise in Capital Expenditures reached 47.9% in 2021, while the deepest fall reached 48.28% in 2021.
• Tracing SKVI's Capital Expenditures over 4 years: stood at $20414.0 in 2021, then slumped by 97.43% to $525.0 in 2022, then sank by 100.19% to -$1.0 in 2023, then changed by 0.0% to -$1.0 in 2025.
• Business Quant data shows SKVI's Capital Expenditures at -$1.0 in Q3 2025, -$1.0 in Q3 2023, and $8809.0 in Q2 2023.